Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow-to-Debt Ratio
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of CN¥400.70 Million could theoretically repay 0% of its total liabilities (CN¥2.05 Billion) in one year. See Shenzhen Salubris Pharmaceuticals Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Also explore 002294 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Shenzhen Salubris Pharmaceuticals Co Ltd. For market capitalisation and broader financial context, see Shenzhen Salubris Pharmaceuticals Co Ltd (002294) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.69x | CN¥1.19 Billion | CN¥1.71 Billion | ▲ +6.8% |
| 2023 | 0.65x | CN¥869.79 Million | CN¥1.34 Billion | ▲ +18.8% |
| 2022 | 0.55x | CN¥970.80 Million | CN¥1.78 Billion | ▼ -44.8% |
| 2021 | 0.99x | CN¥1.18 Billion | CN¥1.20 Billion | ▼ -4.5% |
| 2020 | 1.04x | CN¥1.37 Billion | CN¥1.33 Billion | ▼ -26.7% |
| 2019 | 1.41x | CN¥1.51 Billion | CN¥1.07 Billion | ▲ +8.9% |
| 2018 | 1.30x | CN¥1.34 Billion | CN¥1.03 Billion | ▼ -37.2% |
| 2017 | 2.07x | CN¥1.46 Billion | CN¥705.86 Million | ▲ +54.6% |
| 2016 | 1.34x | CN¥1.43 Billion | CN¥1.07 Billion | ▼ -12.6% |
| 2015 | 1.53x | CN¥1.06 Billion | CN¥691.25 Million | ▲ +28.8% |
| 2014 | 1.19x | CN¥982.25 Million | CN¥827.95 Million | ▼ -9.8% |
| 2013 | 1.32x | CN¥668.52 Million | CN¥508.36 Million | ▼ -5.6% |
| 2012 | 1.39x | CN¥521.21 Million | CN¥374.02 Million | ▲ +58.9% |
| 2011 | 0.88x | CN¥272.32 Million | CN¥310.52 Million | ▲ +45.4% |
| 2010 | 0.60x | CN¥186.65 Million | CN¥309.50 Million | ▼ -33.3% |
| 2009 | 0.90x | CN¥134.28 Million | CN¥148.59 Million | ▲ +69.0% |
| 2008 | 0.53x | CN¥77.89 Million | CN¥145.70 Million | ▲ +11.5% |
| 2007 | 0.48x | CN¥52.75 Million | CN¥109.98 Million | ▲ +108.5% |
| 2006 | 0.23x | CN¥12.00 Million | CN¥52.19 Million | — |